AGLE   $0.5422  3.48% Market Closed

Last Events:

2023-07-18 Trend pattern changed from расходящийся клин с наклоном вниз to канал.

2023-07-18 Signal in Stochastic changed from bullish reversal to bullish recovery. The stochastic indicator is in the upper part of the neutral territory and it heading north. These factors indicate that positive dynamics is recovering. Last signal: main and signal line crossing.

2023-07-18 Signal in MACD changed from bullish reversal to bullish. Oscillator MACD is in the positive territory it's higher than the signal line and grows. These factors mean that positive mood prevails. Last signal: signal line crossed the middle level.

2023-07-18 Signal in RSI changed from bearish recovery to bullish recovery. RSI indicator is in overbought territory and it heading north. These factors indicate that the upside potential still holds even though the market is overbought. Last signal: entrance to the overbought zone.

2023-07-18 Signal in EMA100 changed from bearish reversal to bullish reversal. 2023-06-22 the price crossed up the moving average line and formed a short-term upside trend.

2023-07-18 Signal in EMA50 changed from bearish reversal to bullish reversal. 2023-06-22 the price crossed up the moving average line and demonstrates a strong upside trend.

2023-07-18 Signal in EMA20 changed from bearish reversal to bullish reversal. 2023-06-22 the price crossed up the moving average line and demonstrates an upside trend.

2023-07-18 Trend Power changed from to slow.


Current temperature: 0.91
ST: 0, Cor:

50-50 Year Forecast
Low with 50% probability: 0.22
Target: 3.12
High with 50% probability: 1.28
Analyst Recommendations:
Number of estimates 3
Target Price Mean 3.12
Mean unverified/preliminary 3.12 / 3.12
Target Price Low / High 0.35 / 6.00
Median / STD DEV 3.00 / 2.83
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell Sell
rsi Sell Sell Sell
macd - Sell -
stoch Sell - -
ma20 - Sell -
ma50 Sell - -
ma100 Sell Sell -
Candlestick PatternJuly 13, 2023 Bearish Harami - consists of an unusually large white body followed by a small black body contained within. Large white body It is considered as a bearish pattern when preceded by an uptrend.
ISIN US00773J1034
ceo Mr. Jeffrey M. Goldberg
Website https://www.aeglea.com
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of rare metabolic diseases. The company's therapeutic candidates include pegtarviliase, a polyethylene glycol modified, which is in Phase I/II clinical trial for the treatment of patient with homocystinuria; and pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy for the treatment of Arginase 1 deficiency. In addition, its preclinical pipeline includes AGLE-325 for the treatment of cystinuria, as well as other research programs. The company was formerly known as Aeglea BioTherapeutics Holdings, LLC and changed its name to Aeglea BioTherapeutics, Inc. in March 2015. Aeglea BioTherapeutics, Inc. was founded in 2013 and is headquartered in Austin, Texas.